All posts tagged
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
French Hepatitis Cure is on Track with Positive Phase I Results
Greener Pastures for Biotech? 11 Great Biotechs from Ireland
Two Big Pharma Players Team up to Take Over the NASH Space
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV
More News! Trump targets Pharma, €1B Deal for Ipsen, & a Hep B update
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Allergan signs massive €3Bn Alzheimer deal
In the end, Pfizer will NOT become an Irish Company #noguinnessforpfizer
Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!
Labiotech UG, All Rights Reserved -
Send this to friend